Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

Quoc-Dien Trinh; Daniel J. George; Neal Shore; Egils Vjaters; David Olmos; Andrea Juliana P. de Santana Gomes; Augusto Cesar de Andrade Mota; Natasha Littleton; Shankar Srinivasan; Frank Verholen; Kunhi Parambath Haresh; Fred Saad

doi:10.1097/01.JU.0001109908.15997.76.01

Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

Quoc-Dien Trinh, Daniel J. George, Neal Shore, Egils Vjaters, David Olmos, Andrea Juliana P. de Santana Gomes, Augusto Cesar de Andrade Mota, Natasha Littleton, Shankar Srinivasan, Frank Verholen, Kunhi Parambath Haresh, Fred Saad

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	MP16-01
Pages (from-to)	e578
Number of pages	1
Journal	Journal of Urology
Volume	213
Issue number	5S Suppl.
DOIs	https://doi.org/10.1097/01.JU.0001109908.15997.76.01
Publication status	Published - May 2025
Externally published	Yes

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/01.JU.0001109908.15997.76.01

EFFICACY AND SAFETY OF DAROLUTAMIDE PLUSFinal published version, 96.9 KB

Cite this

Trinh, Q.-D., George, D. J., Shore, N., Vjaters, E., Olmos, D., Gomes, A. J. P. D. S., Mota, A. C. D. A., Littleton, N., Srinivasan, S., Verholen, F., Haresh, K. P., & Saad, F. (2025). Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial. Journal of Urology, 213(5S Suppl.), e578. Article MP16-01. https://doi.org/10.1097/01.JU.0001109908.15997.76.01

@article{a532361d106643baab60cdac77b43f9d,

title = "Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial",

author = "Quoc-Dien Trinh and George, \{Daniel J.\} and Neal Shore and Egils Vjaters and David Olmos and Gomes, \{Andrea Juliana P. de Santana\} and Mota, \{Augusto Cesar de Andrade\} and Natasha Littleton and Shankar Srinivasan and Frank Verholen and Haresh, \{Kunhi Parambath\} and Fred Saad",

year = "2025",

month = may,

doi = "10.1097/01.JU.0001109908.15997.76.01",

language = "English",

volume = "213",

pages = "e578",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "5S Suppl.",

}

Trinh, Q-D, George, DJ, Shore, N, Vjaters, E, Olmos, D, Gomes, AJPDS, Mota, ACDA, Littleton, N, Srinivasan, S, Verholen, F, Haresh, KP & Saad, F 2025, 'Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial', Journal of Urology, vol. 213, no. 5S Suppl., MP16-01, pp. e578. https://doi.org/10.1097/01.JU.0001109908.15997.76.01

Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial. / Trinh, Quoc-Dien; George, Daniel J.; Shore, Neal et al.
In: Journal of Urology, Vol. 213, No. 5S Suppl., MP16-01, 05.2025, p. e578.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

AU - Trinh, Quoc-Dien

AU - George, Daniel J.

AU - Shore, Neal

AU - Vjaters, Egils

AU - Olmos, David

AU - Gomes, Andrea Juliana P. de Santana

AU - Mota, Augusto Cesar de Andrade

AU - Littleton, Natasha

AU - Srinivasan, Shankar

AU - Verholen, Frank

AU - Haresh, Kunhi Parambath

AU - Saad, Fred

PY - 2025/5

Y1 - 2025/5

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:001467945600035&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1097/01.JU.0001109908.15997.76.01

DO - 10.1097/01.JU.0001109908.15997.76.01

M3 - Meeting Abstract

SN - 0022-5347

VL - 213

SP - e578

JO - Journal of Urology

JF - Journal of Urology

IS - 5S Suppl.

M1 - MP16-01

ER -

Efficacy and Safety of Darolutamide Plus Androgen-deprivation Therapy (adt) in Black Patients with Metastatic Hormone-sensitive Prostate Cancer (mhspc) From the Phase 3 Aranote Trial

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Cite this